Pharmacokinetics [phsf]
Toremifene [orch, phsu]
Humans [humn]
Selective Estrogen Receptor Modulator [horm, phsu]
Purpose [ftcn]
Selective Estrogen Receptor Modulators [horm, phsu]
treatment [ftcn]
Prevention [topp]
Osteoporosis [dsyn]
Cardiovascular disease [dsyn]
Breast Cancer [neop]
Currently [tmco]
Focus [spco]
Intense [qlco]
Toremifene [orch, phsu]
diphenyl [hops, orch]
Ethanol [orch]
FC-1271a [orch, phsu]
PREVENT [phsu]
Bone Resorption [ortf]
rats [mamm]
Weak [sosy]
Estrogen Effects [fndg]
Uterus [bpoc]
Make [ftcn]
Good [qlco]
Drug [phsu]
Osteoporosis [dsyn]
Prevention [topp]
Purpose [ftcn]
Pharmacokinetics [phsf]
Toremifene [orch, phsu]
Humans [humn]
included [ftcn]
Phase I Study [resa]
Methods [inpr]
Single [popg]
Dose [qnco]
Study [mnob]
Healthy Volunteers [popg]
Doses [qnco]
Range [qnco]
mg% [qnco]
mg% [qnco]
Second [qnco]
Study [mnob]
Conduct [inbe]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
Received [qlco]
Repeated [ftcn]
Oral [spco]
Dose [qnco]
mg% [qnco]
Standard [qlco]
Pharmacokinetic Parameters [idcn]
Assessed [acty]
Single [popg]
Dose [qnco]
Study [mnob]
Reach [orgf]
Peak Concentration [qnco]
Tmax [qnco]
Range [qnco]
1 H [elii]
H+ [elii]
Peak Concentration [qnco]
Cmax [qnco]
Range [qnco]
Estimated [qnco]
Terminal Half Life [tmco]
Elimination [phsf]
SD [fndg]
Repeated [ftcn]
Dose [qnco]
Study [mnob]
Tmax [qnco]
Range [qnco]
1 H [elii]
2 H [elii]
weeks [tmco]
2 H [elii]
2 H [elii]
weeks [tmco]
Cmax [qnco]
Range [qnco]
weeks [tmco]
weeks [tmco]
Average [qnco]
Dose Level [qnco]
SD [fndg]
Strong [qlco]
Linear [spco]
Correlation [qlco]
Dose [qnco]
Cmax [qnco]
Dose [qnco]
Area [geoa]
Curve [spco]
Observed [ftcn]
Toremifene [orch, phsu]
Pharmacokinetics [phsf]
Single [popg]
Daily [tmco]
prophylactic use [inbe]
Agent [chvf]
Women [popg]
Susceptible [ftcn]
Osteoporosis [dsyn]
Cardiovascular disease [dsyn]
Breast Cancer [neop]
tested [inpr]
Daily [tmco]
Schedule [inpr]
Hormone replacement therapy [topp]
regimens [inpr]
